Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Aerni, A. Articles by de Quervain, D. J.-F. Search for Related Content PubMed Citation Articles by Aerni, A. Articles by de Quervain, D. J.-F. Posttraumatic Stress Disorder Cognition

Low-Dose Cortisol for Symptoms of Posttraumatic Stress Disorder

OBJECTIVE: Because elevated cortisol levels inhibit memory retrieval in healthy human subjects, the present study investigated whether cortisol administration might also reduce excessive retrieval of traumatic memories and related symptoms in patients with chronic posttraumatic stress disorder (PTSD). METHOD: During a 3-month observation period, low-dose cortisol (10 mg/day) was administered orally for 1 month to three patients with chronic PTSD in a double-blind, placebo-controlled, crossover design. RESULTS: In each patient investigated, there was a significant treatment effect, with cortisol-related reductions of at least 38% in one of the daily rated symptoms of traumatic memories, as assessed by self-administered rating scales. In accordance, Clinician-Administered PTSD Scale ratings assessed after each month showed cortisol-related improvements for reexperiencing symptoms and, additionally, in one patient for avoidance symptoms. CONCLUSIONS: The results of this pilot study indicate that low-dose cortisol treatment reduces the cardinal symptoms of PTSD.

This article has been cited by other articles:

				X.-Y. Wang, M. Zhao, U. E. Ghitza, Y.-Q. Li, and L. Lu Stress Impairs Reconsolidation of Drug Memory via Glucocorticoid Receptors in the Basolateral Amygdala J. Neurosci., May 21, 2008; 28(21): 5602 - 5610. [Abstract] [Full Text] [PDF]

				A. S. Ahmed Post-traumatic stress disorder, resilience and vulnerability Advan. Psychiatr. Treat., September 1, 2007; 13(5): 369 - 375. [Abstract] [Full Text] [PDF]

				J. I. Bisson Pharmacological treatment of post-traumatic stress disorder Advan. Psychiatr. Treat., March 1, 2007; 13(2): 119 - 126. [Abstract] [Full Text] [PDF]

				W.-H. Cai, J. Blundell, J. Han, R. W. Greene, and C. M. Powell Postreactivation glucocorticoids impair recall of established fear memory. J. Neurosci., September 13, 2006; 26(37): 9560 - 9566. [Abstract] [Full Text] [PDF]

				L. M. Soravia, M. Heinrichs, A. Aerni, C. Maroni, G. Schelling, U. Ehlert, B. Roozendaal, and D. J.-F. de Quervain Glucocorticoids reduce phobic fear in humans PNAS, April 4, 2006; 103(14): 5585 - 5590. [Abstract] [Full Text] [PDF]

				F. Weis, E. Kilger, B. Roozendaal, D. J.-F. de Quervain, P. Lamm, M. Schmidt, M. Schmolz, J. Briegel, and G. Schelling Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: A randomized study J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 277 - 282. [Abstract] [Full Text] [PDF]

				S. Kuhlmann, M. Piel, and O. T. Wolf Impaired Memory Retrieval after Psychosocial Stress in Healthy Young Men J. Neurosci., March 16, 2005; 25(11): 2977 - 2982. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us